Bio-Rad Laboratories BIO Gain (Loss), Foreign Currency Transaction, before Tax
Gain (Loss), Foreign Currency Transaction, before Tax at other companies
Other financials
Where this comes from
Reported directly by Bio-Rad Laboratories in its filing.
Tagged under the XBRL concept us-gaap:ForeignCurrencyTransactionGainLossBeforeTax.
The official record: Bio-Rad Laboratories’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bio-Rad Laboratories's gain (loss), foreign currency transaction, before tax.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bio-Rad Laboratories's gain (loss), foreign currency transaction, before tax?
- Bio-Rad Laboratories (BIO) reported gain (loss), foreign currency transaction, before tax of $2.4M in Q1 2026.
- How has Bio-Rad Laboratories's gain (loss), foreign currency transaction, before tax changed year-over-year?
- Bio-Rad Laboratories's gain (loss), foreign currency transaction, before tax decreased by 11.1% year-over-year, from $2.7M to $2.4M.
- What is the long-term trend for Bio-Rad Laboratories's gain (loss), foreign currency transaction, before tax?
- Over 4 years (2021 to 2025), Bio-Rad Laboratories's gain (loss), foreign currency transaction, before tax has grown at a 24.4% compound annual growth rate (CAGR), from -$2.75M to $6.6M.